Description
PRIME BOLDENON 500 – Boldenone Undecylenate 500mg/ml
PRIME BOLDENON 500 provides a high-concentration formulation of Boldenone Undecylenate, designed for professionals requiring long-acting anabolic support with minimal estrogenic activity. Boldenone is favored for its ability to promote steady gains in lean muscle mass, strength, and vascularity over extended periods.
Mechanism of Action:
Boldenone acts by enhancing nitrogen retention and protein synthesis while increasing appetite and red blood cell count. Its undecylenate ester ensures a slow release, producing stable plasma levels and reducing the need for frequent administration.
Use Case:
Ideal for prolonged bulking phases or strength cycles where consistent, clean muscle development is prioritized. Its low aromatization rate makes it a reliable option for users seeking gains without excessive water retention or estrogenic side effects.
Advantages of High-Concentration Format:
The 500mg/ml potency allows for efficient administration, making it easier to manage injection volume during complex stacking protocols. This is especially useful for users combining multiple agents while minimizing site stress.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.